Research programme: cathepsin K inhibitors - Organon
Alternative Names: ORG 219517Latest Information Update: 27 Jan 2010
At a glance
- Originator Organon
- Class
- Mechanism of Action Cathepsin K inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Osteoporosis
Most Recent Events
- 19 Nov 2007 Organon has been acquired by Schering-Plough